Filing Details
- Accession Number:
- 0001415889-25-006524
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-04 16:26:16
- Reporting Period:
- 2025-03-03
- Filing Date:
- 2025-03-04
- Accepted Time:
- 2025-03-04 16:26:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1759425 | Mirum Pharmaceuticals Inc. | MIRM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614740 | Christopher Peetz | C/O Mirum Pharmaceuticals, Inc. 989 E Hillsdale Blvd., Suite 300 Foster City CA 94404 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-03 | 40,000 | $2.94 | 155,920 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-03 | 19,392 | $46.61 | 136,528 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-03 | 20,608 | $47.19 | 115,920 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2025-03-03 | 40,000 | $0.00 | 40,000 | $2.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 238,487 | 2029-03-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 208,570 | Indirect | By The Peetz Family Trust |
Footnotes
- Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 22, 2024.
- The weighted average sale price for the transaction reported was $46.61, and the range of prices were between $45.82 and $46.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $47.19, and the range of prices were between $46.82 and $47.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- The stock option is fully vested.
Billionaire Hedge Funds
